Literature DB >> 21627049

Profiling epigenetic alterations in disease.

José Ignacio Martín-Subero1, Manel Esteller.   

Abstract

Nowadays, epigenetics is one of the fastest growing research areas in biomedicine. Studies have demonstrated that changes in the epigenome are not only common in cancer, but are also involved in the pathogenesis of noncancerous diseases like immunological, cardiovascular, developmental and neurological/psychiatric disorders. At the same time, during the last years, a technological revolution has taken place in the field of epigenomics, which is defined as the study of epigenetic changes throughout the whole genome. Microarray technologies and more recently, the development of next generation sequencing devices are now providing researchers with tools to draw high-resolution maps of DNA methylation and histone modifications in normal tissues and diseases. This chapter will review the currently available high-throughput techniques for studying the epigenome and their applications for characterizing human diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21627049     DOI: 10.1007/978-1-4419-8216-2_12

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  22 in total

Review 1.  Identification of aberrant pathways and network activities from high-throughput data.

Authors:  Jinlian Wang; Yuji Zhang; Catalin Marian; Habtom W Ressom
Journal:  Brief Bioinform       Date:  2012-01-27       Impact factor: 11.622

2.  Altered DNA methylation profile in idiopathic pulmonary fibrosis.

Authors:  Yan Y Sanders; Namasivayam Ambalavanan; Brian Halloran; Xiangyu Zhang; Hui Liu; David K Crossman; Molly Bray; Kui Zhang; Victor J Thannickal; James S Hagood
Journal:  Am J Respir Crit Care Med       Date:  2012-06-14       Impact factor: 21.405

3.  Has discovery-based cancer research been a bust?

Authors:  R J Epstein
Journal:  Clin Transl Oncol       Date:  2013-09-04       Impact factor: 3.405

Review 4.  Approaches for the study of cancer: towards the integration of genomics, proteomics and metabolomics.

Authors:  Juan Casado-Vela; Arancha Cebrián; María Teresa Gómez del Pulgar; Juan Carlos Lacal
Journal:  Clin Transl Oncol       Date:  2011-09       Impact factor: 3.405

5.  Next generation sequencing in cardiovascular diseases.

Authors:  Francesca Faita; Cecilia Vecoli; Ilenia Foffa; Maria Grazia Andreassi
Journal:  World J Cardiol       Date:  2012-10-26

6.  Gene expression profiling of epigenetic chromatin modification enzymes and histone marks by cigarette smoke: implications for COPD and lung cancer.

Authors:  Isaac K Sundar; Irfan Rahman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-10-28       Impact factor: 5.464

7.  RNF20 and USP44 regulate stem cell differentiation by modulating H2B monoubiquitylation.

Authors:  Gilad Fuchs; Efrat Shema; Rita Vesterman; Eran Kotler; Zohar Wolchinsky; Sylvia Wilder; Lior Golomb; Ariel Pribluda; Feng Zhang; Mahmood Haj-Yahya; Ester Feldmesser; Ashraf Brik; Xiaochun Yu; Jacob Hanna; Daniel Aberdam; Eytan Domany; Moshe Oren
Journal:  Mol Cell       Date:  2012-06-08       Impact factor: 17.970

8.  Neonatal activation of the nuclear receptor CAR results in epigenetic memory and permanent change of drug metabolism in mouse liver.

Authors:  Wei-Dong Chen; Xianghui Fu; Bingning Dong; Yan-Dong Wang; Steven Shiah; David D Moore; Wendong Huang
Journal:  Hepatology       Date:  2012-10       Impact factor: 17.425

9.  Cigarette smoke induces distinct histone modifications in lung cells: implications for the pathogenesis of COPD and lung cancer.

Authors:  Isaac K Sundar; Michael Z Nevid; Alan E Friedman; Irfan Rahman
Journal:  J Proteome Res       Date:  2013-12-13       Impact factor: 4.466

Review 10.  The role of genetics in the establishment and maintenance of the epigenome.

Authors:  Covadonga Huidobro; Agustin F Fernandez; Mario F Fraga
Journal:  Cell Mol Life Sci       Date:  2013-03-10       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.